These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 17966685)

  • 21. Principles in pharmacogenetics.
    Roden DM
    Epilepsia; 2001; 42 Suppl 5():44-8. PubMed ID: 11887967
    [No Abstract]   [Full Text] [Related]  

  • 22. A thorough QT/QTc study of the effect of fasiglifam, a GPR40 agonist, on cardiac repolarization in healthy adults.
    Lee RD; Nudurupati S; Marcinak J; Viswanathan P
    Clin Pharmacol Drug Dev; 2015; 4(3):175-83. PubMed ID: 27140797
    [TBL] [Abstract][Full Text] [Related]  

  • 23. My Approach to the patient with a borderline long QT interval.
    Roston T; Krahn AD
    Trends Cardiovasc Med; 2017 Oct; 27(7):516-517. PubMed ID: 28684210
    [No Abstract]   [Full Text] [Related]  

  • 24. Long QT syndrome caused by noncardiac drugs.
    Viskin S; Justo D; Halkin A; Zeltser D
    Prog Cardiovasc Dis; 2003; 45(5):415-27. PubMed ID: 12704598
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A sodium channel pore mutation causing Brugada syndrome.
    Pfahnl AE; Viswanathan PC; Weiss R; Shang LL; Sanyal S; Shusterman V; Kornblit C; London B; Dudley SC
    Heart Rhythm; 2007 Jan; 4(1):46-53. PubMed ID: 17198989
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Long QT syndrome: from clinical discovery to molecular etiopathogenesis].
    Czajkowski V; Kulbertus H
    Rev Med Liege; 1998 Apr; 53(4):199-207. PubMed ID: 9641014
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Genetic risk for acquired arrhythmia.
    Behr ER; McKenna WJ
    Trends Genet; 2003 Sep; 19(9):470-3. PubMed ID: 12957537
    [No Abstract]   [Full Text] [Related]  

  • 28. Electrocardiographic biomarkers to confirm drug's electrophysiological effects used for proarrhythmic risk prediction under CiPA.
    Vicente J; Hosseini M; Johannesen L; Strauss DG
    J Electrocardiol; 2017; 50(6):808-813. PubMed ID: 28928044
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Latent genetic backgrounds and molecular pathogenesis in drug-induced long-QT syndrome.
    Itoh H; Sakaguchi T; Ding WG; Watanabe E; Watanabe I; Nishio Y; Makiyama T; Ohno S; Akao M; Higashi Y; Zenda N; Kubota T; Mori C; Okajima K; Haruna T; Miyamoto A; Kawamura M; Ishida K; Nagaoka I; Oka Y; Nakazawa Y; Yao T; Jo H; Sugimoto Y; Ashihara T; Hayashi H; Ito M; Imoto K; Matsuura H; Horie M
    Circ Arrhythm Electrophysiol; 2009 Oct; 2(5):511-23. PubMed ID: 19843919
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Genetics of cardiac arrhythmias.
    Wilde AA; Bezzina CR
    Heart; 2005 Oct; 91(10):1352-8. PubMed ID: 16162633
    [No Abstract]   [Full Text] [Related]  

  • 31. Drug-induced prolongation of the QT interval.
    Roden DM
    N Engl J Med; 2004 Mar; 350(10):1013-22. PubMed ID: 14999113
    [No Abstract]   [Full Text] [Related]  

  • 32. Use of ranolazine in long-QT syndrome type 3.
    Kaufman ES
    J Cardiovasc Electrophysiol; 2008 Dec; 19(12):1294-5. PubMed ID: 18662183
    [No Abstract]   [Full Text] [Related]  

  • 33. Drug-induced QT prolongation in cirrhotic patients with transjugular intrahepatic portosystemic shunt.
    Vuppalanchi R; Juluri R; Ghabril M; Kim S; Thong N; Gorski JC; Chalasani N; Hall SD
    J Clin Gastroenterol; 2011 Aug; 45(7):638-42. PubMed ID: 20962670
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CredibleMeds.org: What does it offer?
    Woosley RL; Black K; Heise CW; Romero K
    Trends Cardiovasc Med; 2018 Feb; 28(2):94-99. PubMed ID: 28801207
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Autonomic tone attenuates drug-induced QT prolongation.
    Smith AH; Norris KJ; Roden DM; Kannankeril PJ
    J Cardiovasc Electrophysiol; 2007 Sep; 18(9):960-4. PubMed ID: 17666066
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Anchoring proteins and cardiac sudden death: how and why?].
    Pourrier M; Nattel S
    Med Sci (Paris); 2004 Apr; 20(4):437-41. PubMed ID: 15124116
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [An unusual cause of cardiac arrest].
    Campana A; Manzo M; Brigante M; Marrazzo N; Melchiorre G
    Ital Heart J Suppl; 2003 Jun; 4(6):510-3. PubMed ID: 19400057
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Congenital and acquired long QT syndromes.
    Walker BD; Krahn AD; Klein GJ; Skanes AC; Wang J; Hegele RA; Yee R
    Can J Cardiol; 2003 Jan; 19(1):76-87. PubMed ID: 12571698
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Thorough QT studies and indirect causes of QTc changes.
    Malik M; Stockbridge N
    Pacing Clin Electrophysiol; 2012 Dec; 35(12):1411-2. PubMed ID: 23035657
    [No Abstract]   [Full Text] [Related]  

  • 40. Effect of ponesimod, a selective S1P1 receptor modulator, on the QT interval in healthy individuals.
    Hoch M; Darpo B; Brossard P; Zhou M; Stoltz R; Dingemanse J
    Basic Clin Pharmacol Toxicol; 2015 May; 116(5):429-37. PubMed ID: 25287214
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.